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Injuries accounted for 9% of global deaths and 12% of the global
burden of disease in 2000.1 In South Africa injury accounts for
25% of male and 10% of female deaths.2 The rate of injury-
related deaths for males in South Africa (239/100 000) is more
than twice the global rate (112.1/100 000).1 However, non-fatal
injuries or injuries that are not immediately fatal are likely to
place the greatest burden on the health sector. 
A recent quantitative, international review of risk factors for
preventing disease and injury suggests that alcohol, and to a
lesser extent illicit drugs, are important causes of intentional
and unintentional injuries.3 While there is substantial literature
on the association between alcohol and injury, there have been
few published studies looking at the role of illicit drug use and
injury, especially in developing countries. In the present study
annual investigations were conducted from 1999 to 2001 to
determine the extent of drug use among patients at trauma
units in Cape Town, Durban and Port Elizabeth (PE).
Methods
Patients presenting with recent injuries (less than 6 hours old) at
the trauma units of Groote Schuur and G F Jooste hospitals in
Cape Town, Livingstone and Provincial hospitals in PE, and
Addington Hospital in Durban were included in each of 3
surveys conducted annually from 1999 to 2001. The concept of
an ‘idealised week’ was used for sampling purposes in order to
ensure that each day of the week was adequately represented.
Each day was divided into four 6-hour shifts. One shift was
randomly selected per day so that over the 4-week study period
a complete 24-hour period would be covered for each day.
Patients attending during these times were included provided
that they gave written consent and did not meet any of the
exclusion criteria. Poisonings, non-traumatic attempted suicides
and paediatric patients were excluded from the study. Patients
who had been referred by other treatment facilities were
included if they had not received significant treatment at the
first facility they attended. 
The Cape Town surveys took place during February and
March of the 3 respective years, the Durban surveys during
June and July, and the PE surveys during August and
September. A total of 1 565 patients were included across the 3
sites and the 3 years. Socio-demographic data were recorded as
well as the cause and type of injuries sustained. Participants
were asked if they had used any drugs before their injury and a
urine specimen was collected and analysed using the Acon
Multi Drug kit, which tests for cannabis, opiates, cocaine,
amphetamine and methamphetamine. Samples were analysed
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Objective. To assess the extent of cannabis and other drug use
among patients presenting with recent injuries at trauma units
in Cape Town, Port Elizabeth and Durban from 1999 to 2001.
Design. Cross-sectional surveys were conducted during a 4-
week period at each of the above sites in 1999, 2000 and 2001.
The concept of an idealised week was used to render
representative samples.
Outcome measures. Cause of injury and biological markers to
assess use of cannabis, methaqualone (Mandrax), opiates,
cocaine, amphetamine, and methamphetamine.
Results. Over half of all patients tested experienced violent
injuries. Excluding opiates, across sites and over time between
33% and 62% of patients tested positive for at least one drug
(N = 1 565). In most cases the drugs were cannabis and/or
methaqualone. While no inter-city differences were found,
male patients were typically more likely to test positive for
drugs in general and specific drugs such as cannabis and the
cannabis/methaqualone (‘white pipe’) combination than
female patients. Drug positivity was higher in 2001 than in the
previous 2 years in Cape Town, and patients injured as a
result of violence in Cape Town and Durban were more likely
to test positive for drugs than patients with certain other types
of injuries.
Conclusions. Drug use among trauma patients has remained
consistently high for each of the 3 study periods. Efforts to
combat the abuse of drugs such as cannabis and
methaqualone would appear to be paramount in reducing the
burden of injuries on health care services. The study has
raised numerous issues requiring further research. 
S Afr Med J 2005; 95: 428-431.
429-432 q5  5/25/05  12:51 PM  Page 429
ORIGINAL ARTICLES
430
June 2005, Vol. 95, No. 6  SAMJ
Tab
le I.  D
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C
ape Tow
n 
PE
D
urban
1999                 2000
2001
1999                  2000                 2001
1999                   2000
2001
G
end
er (N
(%
) )
M
ale
164
(75.9)
154
(75.5)
86
(86.0)
165
(70.5)
141
(70.1)
117
(68.8)
120
(75.9)
104
(69.8)
113
(85.0)
Fem
ale
52
(24.1)
50
(24.5)
14
(14.0) 
69
(29.5)
60
(29.9)
53
(31.2)
38
(24.1)
45
(30.2)
20
(15.0)
M
ean age (years) (±
SD
)
32.6 (11.8)
30.1 (12.0)
31.2 (11.5)
32.9 (11.8)
34.3 (13.4)
32.6 (13.0)
29.2 (11.6)
31.8 (13.7)
28.3 (10.6)
Type of injury (N
(%
) )
V
iolent
131
(60.6)
122
(59.8)
63
(63.0)
151
(64.5)
137
(68.2)
119
(70.0)
87
(55.1)
82
(55.0)
90
(67.7)
Transport
46
(21.3)
36
(17.6)
22
(22.0)
52
(22.2)
26
(12.9)
24
(14.1)
25
(15.8)
37
(24.8)
16
(12.0)
O
ther
39
(18.1)
46
(22.6)
15
(15.0)
31
(13.3)
38
(18.9)
27
(15.9)
46
(29.1)
30
(20.1)
27
(20.3)
Positivity by d
rug of abuse (N
(%
) )
C
annabis (A
con)
72
(33.3)
66
(32.4)
58
(58.0)
100
(42.7)
40
(19.9)
47
(28.7)
48
(30.4)
50
(33.6)
58
(43.9)
C
annabis (lab)
71
(32.9)
72
(35.3)
59
(59.0)
100
(42.7)
52
(25.9)
41
(25.0)
54
(34.2)
52
(34.9)
52
(39.4)
M
ethaqualone
47
(21.8)
40
(19.6)
35
(35.0)
31
(13.2)
22
(10.9)
18
(11.0)
18
(11.4)
11
(7.4)
25
(18.9)
C
ocaine
7
(3.2)
5
(2.5)
7
(7.0)
0
(0)
27
(13.4)
0
(0)
4
(2.5)
6
(4.0)
4
(3.0)
M
etham
phetam
ine
0
(0)
1
(0.5)
0
(0)
0
(0)
0
(0)
0
(0)
1
(0.6)
1
(0.7)
0
(0)
A
m
phetam
ine
0
(0)
3
(1.5)
0
(0)
0
(0)
0
(0)
6
(3.7)
0
(0.0)
0
(0)
1
(0.8)
O
piates
16
(7.4)
21
(10.3)
4
(4.0)
0
(0)
13
(6.5)
4
(2.4)
7
(4.4)
10
(6.7)
7
(5.3)
W
hite pipe*
45
(20.8)
35
(17.2)
35
(35.0)
31
(13.2)
21
(10.4)
18
(11.0)
16
(10.1)
11
(7.4)
21
(15.9)
A
ny d
rug+
73
(36.5)
68
(37.2)
59
(61.5)
100
(42.7)
70
(37.2)
54
(32.5)
54
(35.8)
51
(36.7)
57
(45.2)
A
ny d
rug (m
ales only) +
67
(44.4)
61
(43.9)
53
(63.9)
90
(54.5)
59
(44.4)
38
(33.0)
50
(43.9)
47
(48.0)
54
(50.5)
A
ny d
rug (fem
ales only) +
6
(12.2)
7
(15.9)
6
(46.2)
10
(14.5)
11
(20.0)
16
(31.4)
4
(10.8)
4
(9.8)
3
(15.8)
Positivity for any d
rug by type of 
injury (N
(%
) )
V
iolent
53
(42.4)
44
(40.7)
41
(66.1)
67
(44.4)
45
(35.4)
40
(34.2)
39
(45.9)
34
(45.3)
44
(50.0)
Transport
11
(27.5)
15
(46.9)
11
(55.0)
22
(42.3)
11
(45.8)
7
(29.2)
3
(12.0)
8
(21.6)
6
(37.5)
O
ther unintentional
9
(25.7)
9
(20.5)
7
(50.0)
11
(35.5)
14
(37.8)
7
(28.0)
12
(29.3)
9
(33.3)
7
(31.8)
* A
‘w
hite pipe’ is a com
bination of cannabis and
 m
ethaqualone, usually sm
oked
 in a pipe.
+
 E
xclud
es opiates because of the possibility of m
orphine having been taken/
ad
m
inistered
 before arriving at the traum
a unit.  T
he laboratory result for cannabis w
as used
 in calculating positivity on ‘any d
rug’.
for methaqualone (Mandrax) by the
Department of Pharmacology of the
University of Cape Town, using a
homogeneous enzyme immunoassay
technique (EMIT). Subjects were
considered to have tested positive if
their levels exceeded 300 ng/ml. The
cannabis result obtained from the
drug kit was verified with laboratory
testing. Tests were considered
positive for cannabis if levels
exceeded 25 ng/ml.
Logistical regression analyses were
undertaken to assess the differences
between the 3 cities and the 3 years in
terms of: (i) the percentage of patients
testing positive for specific drugs;
and (ii) the percentage testing
positive for any drug by type of
injury (violence, transport and other
unintentional injury). In addition,
logistical regression analyses were
undertaken to test for city, time and
gender effects related to testing
positive for any drug. 
Results
Sample characteristics
Consistently across the 3 cities and in
each year of the survey over two-
thirds of the subjects were male
(Table I). The mean age across sites
and time periods ranged between 28
years and 34 years. Between 55.0%
and 70.0% of the injuries sustained
across the 3 cities and for each year of
the survey were a result of violence.
Road traffic and other unintentional
injuries (e.g. falls, burns, near-
drowning, etc.) constituted the
remainder of the injuries.
Urinalysis results
Excluding opiates, as some patients
may have received morphine before
arriving at the trauma unit, across
sites and over time between 32.5%
and 61.5% of patients tested positive
for at least 1 drug (Table I). For male
patients the percentages testing
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positive ranged between 33.0% and 63.9%, compared with
between 9.8% and 46.2% for female patients. In most cases the
drugs were cannabis and/or methaqualone. 
The laboratory screening for cannabis showed that across
sites and over the 3 time periods between 25.0% and 59.0% of
patients tested positive for this drug, and between 7.4% and
35.0% of patients tested positive for methaqualone and
cannabis, the so-called ‘white pipe’ combination. Relatively few
patients tested positive for cocaine, generally between 2% and
7%; however there was a ‘spike’ in PE in 2000 when 13.4% of
patients tested positive. Opiates were found among 0% and
10.3% of the urine samples. In addition, very few patients tested
positive for amphetamine or methamphetamine, with a
maximum of 3.7% for amphetamines in PE in 2001. 
For cannabis, a statistically significant interaction was found
between city and year of injury (p < 0.0001).  Specifically for
Cape Town, the percentage of patients testing positive was
significantly higher in 2001 than in 1999 (p = 0.0020) and 2000 (p
= 0.0251). Conversely, in PE the percentage of patients testing
positive for cannabis was significantly higher in 1999 than in
2001 (p < 0.0001), and for Durban no differences by year were
noted.
For ‘white pipes’, no statistically significant interaction was
found between city and year of injury (p = 0.1790), but
differences were found in terms of the percentage of patients
testing positive by city (p < 0.0001) and year of injury (p =
0.0062). For Cape Town, the percentage of patients testing
positive for ‘white pipes’ was significantly higher in 2001 than
2000 (p =  0.0091). All the other differences were not statistically
significant.
For ‘any drug’, a statistically significant interaction was found
between city and year of injury (p = 0.0013) year of injury and
gender (p = 0.0141), but not between city and gender (p =
0.1849). Specifically, for Cape Town, no significant year and
gender interaction was found (p = 0.8750), but significant year
(p = 0.0097) and gender (p < 0.0001) effects were found. The
percentage of patients testing positive for any drug at this site
was significantly higher in 2001 than in 1999 and 2000 taken
together, but the percentages in 1999 and 2000 were not
independently less than for 2001 (p = 0.0613 and p = 0.2510
respectively). The percentage testing positive for any drug was
significantly lower for females than for males in Cape Town
over all years.
A significant year and gender interaction was found for PE (p
= 0.0014). Specifically, in 1999 the percentage of females testing
positive for any drug in this city was significantly lower than
for males.  For Durban, no significant interaction was found
between the year of injury and gender (p = 0.7255). However, a
significant gender effect was found (p = 0.0001), but no
significant year effect (p = 0.9909). In this city over the 3 years
females were found to be less likely to test positive for any drug
than males (p = 0.0001).
A statistically significant interaction was also found between
city and type of injury (p = 0.0075), city and year of injury (p =
0.0004), but not between year and type of injury (p = 0.4720).
For Cape Town, the percentage of patients testing positive for
any drug was significantly higher for violent injuries than for
‘other unintentional’ injuries (p = 0.0209). For Durban the
percentage of patients testing positive for any drug was
significantly higher for violent injures than for transport injuries
(p = 0.0128).  All the other differences were not statistically
significant.
Discussion
Over time between 33% and 62% of patients tested positive for
at least 1 drug. Research conducted at the 3 study sites at the
same time to assess acute alcohol intoxication4 found that across
sites and over time between 36% and 79% of trauma unit
patients tested positive for alcohol, suggesting that the
association with drug use comprises a substantial part of the
total association between substance use and trauma. Studies in
other countries have found similar proportions of trauma
patients testing positive for drugs. For example, a study of 516
patients admitted to a level I trauma centre in Los Angeles,
California,5 found that 42% of the patients tested positive for
drugs, mostly cocaine and opiates. The Los Angeles study also
found much higher levels of drug use among males. 
The levels of cannabis and methaqualone use found in this
study in Cape Town in 2001 (59.0%, 95% confidence interval
(CI): 48.7 - 68.7% for cannabis, and 35.0%, CI: 25.7 - 45.2% for
methaqualone) are significantly higher than those reported in
earlier research conducted in Cape Town in 1997 (22.8%, CI: 17.6
- 28.0%, and 9.4%, CI: 5.8 - 13.0% respectively).6 The increase in
cannabis/methaqualone use over time in Cape Town reflected
in the trauma unit data is in line with increases noted in
specialist treatment demand for problems associated with these
substances in Cape Town between 1996 and 2000.7 This may
reflect a more widespread burden experienced by the health
community resulting from abuse of these substances.
While there is still debate about the precise effects of cannabis
on driving,8 no research has been conducted on the effect of
methaqualone or the combination of cannabis and
methaqualone on cognitive or psychomotor skills, including
driving and other forms of road use. Methaqualone tablets are
almost always smoked. The tablets are crushed and used
together with cannabis and tobacco in a broken-off bottle neck.
The combination, known as a ‘white pipe’, is usually smoked
by a group of people rather than alone.9 The extent to which
this drug combination may also directly foster violent
behaviour, especially during withdrawal states, is also
unknown. The high prevalence of methaqualone use among
gangsters, especially in Cape Town, complicates this issue as
violent behaviour and the use of methaqualone may simply be
occurring simultaneously without there being any causal
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association. 
While the study did not find any inter-city differences, it did
generally find that: (i) male patients were more likely to test
positive for drugs in general and for specific drugs such as
cannabis and the ‘white pipe’ combination than female patients;
(ii) drug positivity was higher in 2001 than in the previous 2
years in Cape Town; and (iii) patients injured as a result of
violence in Cape Town and Durban were more likely to test
positive for ‘any drug’ than patients having certain other types
of injuries. Research conducted in Canada10 also found
associations between the use of certain drugs and injury type
and indicated, for example, that a higher proportion of patients
who sustained intentional injuries tested positive for cocaine
than for transport-related injuries. However, it found no
differences between injury groups in terms of the proportion of
patients testing positive for cannabis.  
The high incidence of drug use, in general, among trauma
patients in South Africa and elsewhere is of concern. However,
as this study did not investigate the causal links between the
use of drugs and sustaining a fatal or non-fatal injury, further
investigation is required in this regard. Another limitation of
this study was the small number of patients who tested positive
for drugs when broken down by injury type, making the
drawing of conclusions about such linkages difficult.
Furthermore, the sample size did not facilitate making
comparisons of the association between specific drugs and
specific injury types.  The time period studied (3 years) also
posed limits on making strong inferences regarding any
changes over time. These topics warrant further research. In
terms of the current situation, the recent increase in
methamphetamine use that has been shown in Cape Town11
may well be impacting on the demand for trauma services in
this city and requires further investigation. Epidemiological
research has also shown that combined use of cannabis and
alcohol sharply increases crash risk.12 Given the high levels of
alcohol and drug-related trauma in South Africa this is also an
area warranting further aetiological and intervention research.
From a public health perspective the study raises important
implications for the management of patients in trauma units
(physically, medically and psychologically) and for reducing the
burden of drug abuse on trauma services. For example, should
trauma unit staff be given more training in identifying and
handling patients who are under the influence of illicit drugs?
Should trauma units be more involved in referring patients who
are identified or suspected of using drugs to treatment services,
particularly those who are frequent users of trauma services?
The study also raises questions about the level of drug-related
trauma attended to by general practitioners, who as a group
probably deal with more traumatic injuries than specialist
trauma units. 
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